XM does not provide services to residents of the United States of America.

XM does not provide services to residents of the United States of America.
H
H

Hologic

News

Reuters - 3 weeks ago

U.S. STOCKS Crypto, Louisiana-Pacific, Broadridge

BUZZ-U.S. STOCKS ON THE MOVE-Crypto, Louisiana-Pacific, Broadridge Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes rose on Tuesday as technology and chips stocks gained, while investors braced for volatile trading over the next few sessions as voting began in a tightly contested U.S.
A
H
N
D
W
U
U
C
R
B
C
Reuters - 3 weeks ago

Hologic falls on lower-than-expected annual revenue forecast

BUZZ-Hologic falls on lower-than-expected annual revenue forecast ** Shares of medical device maker Hologic HOLX.O fall 4.7% to $79.77, the lowest since August ** HOLX said late on Monday it expects 2025 revenue in range of $4.15 bln to $4.20 bln, below analysts' average estimate of $4.21 bln - LSEG data ** Co said its full-year forecast included an expected impact from ongoing temporary halt in shipping of its bone density scanning machine, Horizon DXA systems ** Co reported Q4 adj.
H
Reuters - 3 weeks ago

Hologic Inc reports results for the quarter ended in January 1 - Earnings Summary

Hologic Inc reports results for the quarter ended in January 1 - Earnings Summary Hologic Inc HOLX.OQ reported quarterly adjusted earnings of $1.01​​ per share for the quarter ended January 1, higher than the same quarter last year, when the company reported EPS of 89 cents. The mean expectation of sixteen analysts for the quarter was for earnings of $1.01 per share.
H
Reuters - 3 weeks ago

U.S. Celanese Corporation, Disc Medicine, Editas Medicine

U.S. RESEARCH ROUNDUP-Celanese Corporation, Disc Medicine, Editas Medicine Nov 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Celanese Corporation, Disc Medicine and Editas Medicine, on Tuesday. HIGHLIGHTS * Affiliated Managers Group Inc AMG.N : TD Cowen cuts to hold from buy * Celanese Corporation CE.N : Wells Fargo cuts to equal weight from overweight * Disc Medicine Inc IRON.O : Raymond James raises to strong b
A
A
B
C
C
E
H
I
M
V
W
E
F
B
C
Reuters - 3 weeks ago

Hologic forecasts lower-than-expected annual sales on equipment shipping halt

Hologic forecasts lower-than-expected annual sales on equipment shipping halt Nov 4 (Reuters) - Medical technology company Hologic HOLX.O said on Monday it anticipates annual revenue below average analysts' estimates, hurt by ongoing temporary pause on shipping of its bone density scanning machines. The Marlborough, Massachusetts-based company manufactures and supplies viral load tests, molecular diagnostics assays, medical imaging systems and surgical products focused on women's health.
H
Reuters - 3 weeks ago

Outliers from Iowa and payrolls sow confusion

MORNING BID AMERICAS-Outliers from Iowa and payrolls sow confusion A look at the day ahead in U.S. and global markets from Mike Dolan With even the Federal Reserve meeting in the shade of Tuesday's election, markets have little to go other than last-minute opinion polls that tilt the tight White House race either way, and Iowa did just that over the weekend.
H
M
M
N
U
W
J
U
U
U
C
E
B
Reuters - 4 weeks ago

FDA In Safety Communication Says Do Not Use BioZorb Marker Implantable Radiographic Marker Devices

BRIEF-FDA In Safety Communication Says Do Not Use BioZorb Marker Implantable Radiographic Marker Devices Oct 25 (Reuters) - FDA: FDA IN SAFETY COMMUNICATION SAYS DO NOT USE BIOZORB MARKER IMPLANTABLE RADIOGRAPHIC MARKER DEVICES FDA: HOLOGIC RECALL DUE TO REPORTS OF SERIOUS ADVERSE EVENTS OCCURRING IN PATIENTS WHO HAD BIOZORB MARKER DEVICES IMPLANTE
H
Reuters - 1 month ago

U.S. STOCKS Bausch + Lomb, SpartanNash, Hologic

BUZZ-U.S. STOCKS ON THE MOVE-Bausch + Lomb, SpartanNash, Hologic Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street rose on Monday, with the S&P 500 and the Dow touching fresh intraday record highs, as investors geared up for a week packed with corporate earnings and crucial economic data that will likely test stretched stock market valuations.
A
A
H
N
N
T
W
K
L
S
T
U
W
U
U
Reuters - 1 month ago

Hologic up on Gynesonics acquisition

BUZZ-Hologic up on Gynesonics acquisition ** Shares of Hologic Inc HOLX.O up 1.3% at $80.8 ** Hologic to acquire Gynesonics in a deal for about $350 million ** Gynesonics, a privately held medical device company, develops minimally invasive solutions for women's health, focusing on treatments like the Sonata System for uterine fibroids ** 9 of 19 b
H
Reuters - 1 month ago

Hologic Inc - To Acquire Gynesonics For Approximately $350 Million

BRIEF-Hologic Inc - To Acquire Gynesonics For Approximately $350 Million Oct 14 (Reuters) - Hologic Inc HOLX.O : HOLOGIC TO ACQUIRE GYNESONICS, DEVELOPER OF MINIMALLY INVASIVE SOLUTIONS FOR WOMEN’S HEALTH HOLOGIC INC - TO ACQUIRE GYNESONICS FOR APPROXIMATELY $350 MILLION Source text for Eikon: ID:nBwcc32Nca Further company coverage: HOLX.O
H
Reuters - 2 months ago

U.S. Humana, Portillos, Waters Corp

U.S. RESEARCH ROUNDUP-Humana, Portillos, Waters Corp Oct 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Humana, Portillos and Waters on Tuesday. HIGHLIGHTS * Frontier Communications Parent Inc FYBR.O : TD Cowen cuts to hold from buy * Humana HUM.N : RBC cuts target price to $265 from $400 * Portillos Inc PTLO.O : Stephens cuts to equal-weight from overweight * Waters Corp WAT.N : Jefferies raises to buy from hold
B
C
C
C
H
C
F
G
S
W
C
C
P
Reuters - 2 months ago

Hologic Inc Says On Sept 12, Board Authorized New Stock Repurchase Program, With Five-Year Term, To Repurchase Up To $1.5 Billion Of Common Stock

BRIEF-Hologic Inc Says On Sept 12, Board Authorized New Stock Repurchase Program, With Five-Year Term, To Repurchase Up To $1.5 Billion Of Common Stock Hologic Inc HOLX.O : HOLOGIC INC SAYS ON SEPT 12, BOARD AUTHORIZED NEW STOCK REPURCHASE PROGRAM, WITH FIVE-YEAR TERM, TO REPURCHASE UP TO $1.5 BILLION OF COMMON STOCK Source text for Eikon: [ID:n000
H
Reuters - 2 months ago

U.S. Constellation Energy, Eli Lilly, Talen Energy

U.S. RESEARCH ROUNDUP-Constellation Energy, Eli Lilly, Talen Energy Sept 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Energy, Eli Lilly and Talen Energy, on Friday. HIGHLIGHTS * Constellation Energy Corp CEG.O : Jefferies initiates with hold rating; target $183 * Eli Lilly LLY.N : JP Morgan raises target price to $1,100 from $1,050 * Moderna MRNA.O : JP Morgan cuts to underweight from neutral * Vo
A
C
C
F
F
H
H
H
I
K
W
F
D
T
Z
A
A
D
E
H
L

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.